Third-party tested — a certificate of analysis ships with every lot
ÉVOLUER Wellness
FOXO4-DRI — Nasal research productFIG. 01 — INTRANASAL PREPARATION
HPLC PURITY
≥99%
Specimen · Batch
FOXO4-DRI · EVX-FOXO-10
Nasal

FOXO4-DRI

$299.00/ 10 mg
Now shipping
  • 10 mg — Batch EVX-FOXO-10 · 99.1% purity

Supplied as lyophilized powder for research use only. Not for human consumption.

1
Ships out today Free shipping over $200 COA included
Save up to 20% on bulk orders
QuantityPrice / unit
3 – 4$290.03
5 – 6$284.05
7 – 9$275.08
10 – 19$263.12
20 +$239.20

Description

FOXO4-DRI is a D-retro-inverso peptide studied in cellular-senescence research. Supplied for laboratory research use only — not for human or veterinary use.

Senescence research
Product usage. Intended exclusively for in-vitro research and laboratory use. Not for human or veterinary use, and not evaluated by the U.S. Food and Drug Administration.

Specifications

CAS No.
Available on COA
Molecular Formula
Available on COA
Molecular Weight
Available on COA
Appearance
White lyophilized powder
Storage
Store at -20°C; 2–8°C after reconstitution
Purity
≥99%
View Test Reports

You might like

Tirzepatide — Tirzepatide research product
Nasal

Tirzepatide

A dual GIP / GLP-1 receptor agonist studied in metabolic research.

99.9% pure10 mg
$169.00
Retatrutide — Retatrutide research product
Nasal

Retatrutide

A triple GLP-1 / GIP / glucagon receptor agonist studied in metabolic research.

99.1% pure10 mg
$179.00
Semaglutide — Semaglutide research product
Nasal

Semaglutide

A GLP-1 receptor agonist studied in metabolic research.

99.5% pure10 mg
$159.00
Tesofensine — Tesofensine research product
Nasal

Tesofensine

A monoamine reuptake inhibitor studied in metabolic and CNS research.

99.6% pure20 mg
$189.00